In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of Zimislecel achieved complete ...

Zimislecel, a novel stem cell therapy, has reportedly demonstrated promising results in an early-phase clinical trial ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...

Discover how zimislecel enables insulin independence in patients with Type 1 diabetes, showing strong efficacy in early ...

A new stem cell-based treatment helped most trial participants with severe type 1 diabetes stop insulin use, offering hope ...

More than 8 million people globally suffer from type 1 diabetes, a condition where the immune system destroys ...

Vertex Pharmaceuticals may have narrowed its focus this year, but the biopharma’s decision to stick with its remaining islet ...

While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target ...

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...